LeishPathNet

LeishPathNet: aiming to develop a global pathology network supporting research on leishmaniasis. #leishmaniasis #neglected #globalchallenges

[HIC-Vac @hic_vac]

Join us for our webinar this week 08/06 12.30 BST "Using public engagement to develop a new CHIM for cutaneous leishmaniasis"
@v1vak @UniOfYork @leishpathnet
Register here https://t.co/c26PmHPgEb

[James Meiring @jamesmeiring]

Great presentations from @SheffieldHosp trainees @biainfection Spring Meeting today. #Vaccines #COVID19 #HIV #Leishmaniasis #Endocarditis #Diagnostics @v1vak @PhilHouse

[Nathaniel Jones @DrNathJones]

Paul Kaye kicking off @BSPparasitology with a history of Parasitology research at @UniOfYork

[Hull York Medical School @HullYorkMed]

Hull York researchers are embarking on an exciting human challenge study, which could pave the way for a new vaccine against tropical disease leishmaniasis. Read more here: https://t.co/7NVb3jwBnI

[University of York @UniOfYork]

Researchers at York are seeking volunteers to take part in a clinical study which aims to develop vaccines against the neglected tropical disease #leishmaniasis: https://t.co/zMXNLSFVCJ
#Yorkreseach @BiologyatYork @YBRI_UoY @HullYorkMed @leishpathnet @v1vak

[York Biomedical Research Institute @YBRI_UoY]

#NewPaper from Prof's Kaye, Layton & Lacey and @v1vak @HullYorkMed 'Overcoming roadblocks in the development of vaccines for leishmaniasis' #review #leishmaniasis #vaccine

https://t.co/IgX8nAKcaG

[Barry Wright @BarryinYork]

@leishpathnet @MaliniPires such an important world disease with far reaching mental health consequences through a variety of routes:

Pires et al (2019). The impact of leishmaniasis on mental health and psychosocial well-being: a systematic review. PloS one, 14(10), e0223313.

[LeishPathNet @leishpathnet]

Now recruiting participants to take part in our controlled human infection study, visit: https://t.co/WC14Q3luyV

@v1vak @YBRI_UoY
(design by @paulreedvideo & @v1vak)

[LeishPathNet @leishpathnet]

Now recruiting participants to take part in our controlled human infection study, visit: https://t.co/WC14Q3luyV

@v1vak @YBRI_UoY
(design by @paulreedvideo & @v1vak)

[York Biomedical Research Institute @YBRI_UoY]

#NewReview: From Profs Lacey, Layton, Kaye & @v1vak @HullYorkMed 'Vaccines against leishmaniasis: using controlled human infection models to accelerate development' #vaccines #leishmaniasis #humanchallenge

https://t.co/woDwW0sUXc

[LeishPathNet @leishpathnet]

Our latest review discussing the pathway to a controlled human infection model for leishmaniasis @v1vak

[York Biomedical Research Institute @YBRI_UoY]

#NewReview: From Profs Lacey, Layton, Kaye & @v1vak @HullYorkMed 'Vaccines against leishmaniasis: using controlled human infection models to accelerate development' #vaccines #leishmaniasis #humanchallenge

https://t.co/woDwW0sUXc

[LeishPathNet @leishpathnet]

A clinical study using uninfected sand flies, on the pathway to a controlled human infection model for leishmaniasis:
https://t.co/WSNnpGWEoB
@v1vak @Profgljones @medvla @WellcomeOpenRes

[Jeremy Mottram @Mottram_group]

I'm delighted that we have a new Wellcome Trust Investigator award to study the interplay of phosphorylation and ubiquitination in Leishmania differentiation. Thanks to @Mottram_group members, collaborators, @YBRI_UoY @BiologyatYork @FillingV. Onwards https://t.co/YLVoEs9ruA

[Vivak Parkash @v1vak]

@YBRI_UoY @leishpathnet @Profgljones @MedicalEvidence @HullYorkMed Although a small part of my overall research, Im very proud of this as 1) its my first foray into #qualitative research and public #involvement and #engagement and how integral it is to research; 2) managed to highlight the diversity issue amongst research participants

[Jeremy Mottram @Mottram_group]

Fantastic progress on a leishmaniasis vaccine from the Kaye lab @YBRI_UoY. All the more disheartening that the UK government has made such savage cuts to GCRF/Newton funded research on leishmaniasis. https://t.co/W1eou4rqve

[Daniel Jeffares @danieljeffares]

Very proud of @biocoopdegrace to find balancing selection in #Leishmania parasites! Part of #JCPiLeish funded by @The_MRC. Thanks to @SallyJamesYork, @YorkBioinfo & Carlos HN Costa at @ufpioficial. @YBRI_UoY @UniOfYork @YorkBiolRes @Mottram_group https://t.co/TTMpmaFla6

[Jeremy Mottram @Mottram_group]

Published! Congrats to all. Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival https://t.co/z3CCyp4yik

[European Vaccine Initiative (EVI) @EuropeVaccine]

#PREV_PKDL, EVI-coordinated project, joins forces with CREDO to strengthen immunology research capacity in East #Africa.
Colleagues at @inrb_kinshasa 🇨🇩 will participate in flow cytometry training programme provided by PREV_PKDL partner @UniOfYork.

@EDCTP
https://t.co/rIhFkosdCk

[Hull York Medical School @HullYorkMed]

In case you missed it! We're excited to offer three brand new #fundedPhD opportunities based at @UniOfYork focusing on immunology, specifically #cancerbiology and #bacterialsepsis. Applications close on 21 Feb. Find out more 👉 https://t.co/bEDmAvMZ6J

[Dr.Bosire Wairimu MD, MSc, MBA,LLB. @Lasterbosire]

In my series of #MedEducation this week I bring to your attention a group of diseases so neglected that they have been named

"Neglected Tropical Diseases"

1 in every 5 people globally is affected yet they continue to receive no attention
#WednesdayMotivation
#WhatsApp

1/4